Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP414692.RAlBdb8R6mgUs0VvdG6Kd75HP7SKNRYzq24yT7cl8ot5k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP414692.RAlBdb8R6mgUs0VvdG6Kd75HP7SKNRYzq24yT7cl8ot5k130_assertion type Assertion NP414692.RAlBdb8R6mgUs0VvdG6Kd75HP7SKNRYzq24yT7cl8ot5k130_head.
- NP414692.RAlBdb8R6mgUs0VvdG6Kd75HP7SKNRYzq24yT7cl8ot5k130_assertion description "[We found 165 IDH1 (72.7%) and 2 IDH2 mutations (0.9%) in 227 diffuse astrocytomas WHO grade II, 146 IDH1 (64.0%) and 2 IDH2 mutations (0.9%) in 228 anaplastic astrocytomas WHO grade III, 105 IDH1 (82.0%) and 6 IDH2 mutations (4.7%) in 128 oligodendrogliomas WHO grade II, 121 IDH1 (69.5%) and 9 IDH2 mutations (5.2%) in 174 anaplastic oligodendrogliomas WHO grade III, 62 IDH1 (81.6%) and 1 IDH2 mutations (1.3%) in 76 oligoastrocytomas WHO grade II and 117 IDH1 (66.1%) and 11 IDH2 mutations (6.2%) in 177 anaplastic oligoastrocytomas WHO grade III.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP414692.RAlBdb8R6mgUs0VvdG6Kd75HP7SKNRYzq24yT7cl8ot5k130_provenance.
- NP414692.RAlBdb8R6mgUs0VvdG6Kd75HP7SKNRYzq24yT7cl8ot5k130_assertion evidence source_evidence_literature NP414692.RAlBdb8R6mgUs0VvdG6Kd75HP7SKNRYzq24yT7cl8ot5k130_provenance.
- NP414692.RAlBdb8R6mgUs0VvdG6Kd75HP7SKNRYzq24yT7cl8ot5k130_assertion SIO_000772 19554337 NP414692.RAlBdb8R6mgUs0VvdG6Kd75HP7SKNRYzq24yT7cl8ot5k130_provenance.
- NP414692.RAlBdb8R6mgUs0VvdG6Kd75HP7SKNRYzq24yT7cl8ot5k130_assertion wasDerivedFrom befree-20140225 NP414692.RAlBdb8R6mgUs0VvdG6Kd75HP7SKNRYzq24yT7cl8ot5k130_provenance.
- NP414692.RAlBdb8R6mgUs0VvdG6Kd75HP7SKNRYzq24yT7cl8ot5k130_assertion wasGeneratedBy ECO_0000203 NP414692.RAlBdb8R6mgUs0VvdG6Kd75HP7SKNRYzq24yT7cl8ot5k130_provenance.